Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Covetrus, Inc.    CVET


SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Covetrus : Appoints Jamey Seely General Counsel

09/01/2020 | 08:35am EST

Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, announces the appointment of Jamey Seely as general counsel and corporate secretary, reporting to Dustin Finer, chief administrative officer at Covetrus.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200901005400/en/

Covetrus Appoints Jamey Seely General Counsel (Photo: Business Wire)

Covetrus Appoints Jamey Seely General Counsel (Photo: Business Wire)

Jamey brings more than 20 years of legal and business experience within the energy, manufacturing and technology industries, including general counsel within two public companies. She has extensive experience in the management of international legal matters and building legal teams throughout the United States, Europe and Asia. Her legal specialties include securities, board governance & compensation, mergers and acquisitions, financing, and project development, along with human resource matters and high-risk litigation management.

“We are thrilled to have Jamey join Covetrus as general counsel and as a member of our board leadership team,” said Dustin Finer. “The Company will benefit from Jamey’s combination of legal and business expertise, and we look forward to her support in driving the Company’s business strategy, development and continued growth.”

Prior to joining Covetrus, Jamey simultaneously held business and legal roles while serving as president and general counsel of Integra, a developer of blockchain technology for the legal industry. Other past posts include EVP and general counsel of the Gates Industrial Corporation, which she led to a successful IPO, and EVP general counsel and corporate secretary at ION Geophysical, Inc.

Jamey succeeds Erin Powers Brennan. “Erin was instrumental in the formation of Covetrus, and in building the strong legal team we have in place today,” said CEO, Ben Wolin. “We are grateful for her service and wish her well.”

Jamey is a graduate of Southern Methodist University’s Dedman School of Law and received a B.A., magna cum laude, from Baylor University. She holds a Professional Certificate in Energy Innovation & Emerging Technologies from Stanford University.

About Covetrus

Covetrus is a global animal-health technology and services company dedicated to empowering veterinary practice partners to drive improved health and financial outcomes. We’re bringing together products, services, and technology into a single platform that connects our customers to the solutions and insights they need to work best. Our passion for the well-being of animals and those who care for them drives us to advance the world of veterinary medicine. Covetrus is headquartered in Portland, Maine, with more than 5,500 employees, serving over 100,000 customers around the globe. Learn more at http://covetrus.com

Forward Looking Statements

This press release contains certain statements that are forward-looking within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and that involve risks and uncertainties, including statements about our plans, objectives, expectations, and intentions. Such statements are subject to numerous risks and uncertainties. Factors that could adversely affect our business and prospects are set forth in our public filings with the Securities and Exchange Commission. Our forward-looking statements are based on current beliefs and expectations of our management team and, except as required by law, we undertake no obligations to make any revisions to the forward-looking statements contained in this release or to update them to reflect events or circumstances occurring after the date of this release, whether as a result of new information, future developments or otherwise. Investors are cautioned not to place undue reliance on these forward-looking statements.

© Business Wire 2020
All news about COVETRUS, INC.
11/18COVETRUS, INC. : Submission of Matters to a Vote of Security Holders, Regulation..
11/10COVETRUS : Management's Discussion and Analysis of Financial Condition and Resul..
11/10COVETRUS : 3Q Earnings Snapshot
11/10COVETRUS, INC. : Results of Operations and Financial Condition, Financial Statem..
11/10COVETRUS : Announces Financial Results for Third Quarter of 2020
11/10Covetrus Announces Financial Results for Third Quarter of 2020
10/27COVETRUS : Announces Third Quarter 2020 Earnings Release Date and Conference Cal..
10/27Covetrus Announces Third Quarter 2020 Earnings Release Date and Conference Ca..
10/09COVETRUS : Makes a Strategic Investment in Veterinary Study Groups, the Premier ..
09/28COVETRUS : Holds Virtual VetSummit Conference - October 16-18
More news
Financials (USD)
Sales 2020 4 272 M - -
Net income 2020 -23,0 M - -
Net Debt 2020 675 M - -
P/E ratio 2020 -111x
Yield 2020 -
Capitalization 3 409 M 3 409 M -
EV / Sales 2020 0,96x
EV / Sales 2021 0,88x
Nbr of Employees 5 300
Free-Float 79,0%
Duration : Period :
Covetrus, Inc. Technical Analysis Chart | CVET | US22304C1009 | MarketScreener
Technical analysis trends COVETRUS, INC.
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 7
Average target price 27,00 $
Last Close Price 26,73 $
Spread / Highest target 16,0%
Spread / Average Target 1,01%
Spread / Lowest Target -25,2%
EPS Revisions
Benjamin C. Wolin President, Chief Executive Officer & Director
Philip A. Laskaway Chairman
Matthew J. Foulston Chief Financial Officer
Georgina Wraight President-Global Technology Solutions & EVP
Steve Palmucci Global Chief Information Officer
Sector and Competitors
1st jan.Capitalization (M$)
COVETRUS, INC.102.50%3 409
MEDTRONIC PLC-2.19%149 189